Intra-Arterial Reteplase Compared to Urokinase for Thrombolytic Recanalization in Acute Ischemic Stroke

References

1. ↵
   The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581–87

   CrossRefPubMedWeb of Science
2. ↵
   Hacke W, Brott T, Caplan L, et al. Thrombolysis in acute ischemic stroke: controlled trials and clinical experience. Neurology 1999;53(suppl 4):s3–s14
3. ↵
   Hacke W, Kaste M, Fieschi C, et al. Randomized double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischemic stroke (ECASS II): Second European-Australasian Acute Stroke Study Investigators. Lancet 1998;352:1245–51

   CrossRefPubMedWeb of Science
4. ↵
   Labiche LA, Al-Senani F, Wojner AW, et al. Is the benefit of early recanalization sustained at 3 months? A prospective cohort study. Stroke 2003;34:695–98

   Abstract/FREE Full Text
5. ↵
   Wolpert SM, Bruckmann H, Greenlee R, et al. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. AJNR Am J Neuroradiol 1993;14:3–13

   Abstract/FREE Full Text
6. ↵
   Alexandrov AV, Demchuk A, Felberg R, et al. High rate of complete recanalization and dramatic clinical recovery during rPA infusion when continuously monitored with 2-mHz transcranial Doppler monitoring. Stroke 2000;31:610–14

   Abstract/FREE Full Text
7. ↵
   Alexandrov AV, Molina CA, Grotta JC, et al. Ultrasound enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 2004;351:2170–78

   CrossRefPubMedWeb of Science
8. Brott TG, Haley EC Jr, Levy DE, et al. Urgent therapy for stroke. Part 1. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke 1992;23:632–40

   Abstract/FREE Full Text
9. Von Krummer R, Hacke W. Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke. Stroke 1992;23:646–52

   Abstract/FREE Full Text
10. ↵
    Trouillas P, Nighoghossian N, Getenet JC, et al. Open trial of intravenous tissue plasminogen activator in acute carotid territory stroke: correlations of outcome with clinical and radiological data. Stroke 1996;27:882–90

    Abstract/FREE Full Text
11. ↵
    Del Zoppo GJ, Higashida RT, Furlan AJ, et al. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke 1998;29:4–11

    Abstract/FREE Full Text
12. ↵
    Furlan A, Higashida R, Wechsler L, et al. Intra-arterial pro-urokinase for acute ischemic stroke: the PROACT II study: a randomized controlled trial. JAMA 1999;282:2003–11

    CrossRefPubMedWeb of Science
13. Ramee SR, Subramanian R, Felberg RA, et al. Catheter-based treatment for patients with acute ischemic stroke ineligible for intravenous thrombolysis. Stroke 2004;35:e109–e111

    Abstract/FREE Full Text
14. ↵
    Quereshi AI, Ali Z, Suri MR, et al. Intra-arterial third generation recombinant tissue plasminogen activator (reteplase) for acute ischemic stroke. Neurosurgery 2001;49:41–48

    CrossRefPubMedWeb of Science
15. Quereshi AI, Ringer AJ, Suri MF, et al. Acute intervention for ischemic stroke: Present status and future directions. J Endovasc Ther 2000;7:423–28

    CrossRefPubMed
16. ↵
    Higashida RT, Furlan AJ, Roberts H, et al. Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 2003;34:e109–e137

    Abstract/FREE Full Text
17. The IMS Study Investigators. Combined intravenous and intra-arterial decimalization for acute ischemic stroke: the interventional management of Stroke Study. Stroke 2004;35:904–912

    Abstract/FREE Full Text
18. Noser EA, Shaltoni HM, Hall CE, et al. Aggressive mechanical clot disruption: a safe adjunct to thrombolytic therapy in acute stroke? Stroke 2005;36:292–96

    Abstract/FREE Full Text
19. Zadiat O, Suarez J, Santillan C, et al. Response to intra-arterial and combined intravenous and intra-arterial thrombolytic therapy in patients with distal internal carotid artery occlusion. Stroke 2002;33:1821–27

    Abstract/FREE Full Text
20. Keris V, Rudnicka S, Vorona V, et al. Combined intraarterial/intravenous thrombolysis for acute ischemic stroke. AJNR AM J Neuroradiol 2001;22:352–58

    Abstract/FREE Full Text
21. Ringer AJ, Quereshi AI, Fessler RD, et al. Angioplasty of intracranial occlusion resistant to thrombolysis in acute ischemic stroke. Neurosurgery 2001;48:1282–90

    CrossRefPubMedWeb of Science
22. ↵
    Lee KY, Kim DI, Kim SH, et al. Sequential combination of intravenous recombinant tissue plasminogen activator and intra-arterial urokinase in acute ischemic stroke. AJNR Am J Neuroradiol 2004;25:1470–75

    Abstract/FREE Full Text
23. ↵
    Smalling RW, Bode C, Kalbfleisch J, et al. More rapid, complete, and stable coronary thrombolysis with bolus administration of reteplase compared with alteplase infusion in acute myocardial infarction. Circulation 1995;91:2725–32

    Abstract/FREE Full Text
24. INJECT Study Group. Randomized, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalence. Lancet 1995;349–36
25. ↵
    Noble S, McTavish D. Reteplase: A review of its pharmacological properties and clinical efficacy in the management of acute myocardial infarction. Drugs 1996;52:589–605

    PubMedWeb of Science
26. ↵
    Quereshi AI, Siddiqui AM, Suri MF, et al. Aggressive mechanical clot disruption and low-dose intra-arterial third-generation thrombolytic agent for ischemic stroke: a prospective study. Neurosurgery 2002;51:1319–29

    PubMedWeb of Science
27. ↵
    Urokinase Pulmonary Embolism Trial Study Group. Urokinase-streptokinase embolism trial. Circulation 1974;229:1606–13
28. ↵
    Tennant SN, Dixon J, Venable TC, et al. Intracoronary thrombolysis in acute myocardial infarction: comparison of the efficacy of urokinase to streptokinase. Circulation 1984;69:756–60

    Abstract/FREE Full Text
29. ↵
    Ionue T, Kimura K, Minematsu K, et al. A case-control analysis of intra-arterial urokinase thrombolysis in acute cardioembolic stroke. Cerebrovasc Dis 2005;19:225–28

    CrossRefPubMedWeb of Science
30. ↵
    Pettersen JA, Hudon ME, Hill MD. Intra-arterial thrombolysis in acute ischemic stroke: a review of pharmacologic approaches. Expert Rev Cardiovasc Ther 2004;2:285–99

    PubMed
31. ↵
    Larrue V, Von Krummer R, Del Zoppo G, et al. Hemorrhagic transformation in acute ischemic stroke. Stroke 1997;28:957–60

    Abstract/FREE Full Text
32. ↵
    Wardlaw JM, Warlow CT. Thrombolysis in acute ischemic stroke: does it work? Stroke 1992;23:1826–39

    Abstract/FREE Full Text
33. ↵
    Mori E, Tabuchi M, Yoshida T, et al. Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery. Stroke 1988;19:802–12

    Abstract/FREE Full Text
34. ↵
    Deitcher SR, Jaff MR. Pharmacologic and clinical characteristics of thrombolytic agents. Rev Cardiovasc Med 2002;3:s25–s33